Lataa...
MON-461 Drug Repurposing to Explore Novel Treatment for Cushing Disease
Cushing Disease (CD), caused by adrenocorticotropic hormone (ACTH)-secreting pituitary adenomas, leads to excess production of adrenal-derived cortisol. Current medical treatments for CD include adrenal steroidogenesis inhibitors (Ketoconazole, Metyrapone), the somatostatin receptor ligand Pasireoti...
Tallennettuna:
| Julkaisussa: | J Endocr Soc |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Endocrine Society
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6550912/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-MON-461 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|